STD therapeutics market size is expected to show lucrative growth rate during the study time line owing to increasing number of technologically developed products in diagnostics field, offering accurate test results. In addition, shifting trend towards rapid point of care testing from traditional laboratories is fuelling the business growth rate.
Development of the healthcare infrastructure along with increasing per capita income are other key factors aiding the industry revenue generation. Improving infrastructure for testing services and new diagnostics is facilitating better treatment alternatives for STDs, thereby boosting the STD therapeutics market share till 2027.
The avionics market is segmented on the lines of its type, location of testing, testing device and regional. The basis of type the market is segmented into Chlamydia Testing, Syphilis Testing, Gonorrhoea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, and others. Based on location of testing the global avionics market covers Laboratory Testing and Point of Care Testing. On the basis of testing device, the market is segregated into Laboratory Devices and Point of Care Devices. The avionics market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for selected countries such as the U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
DiaSorin, Roche Holdings AG, Alere Inc., Abbott Laboratories, Danaher Corporation, bioMerieux, Becton Dickinson and Company, Affymetrix, Hologic Inc., Cepheid Inc., and Orasure are among the major players in the global avionics market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Sexually Transmitted Disease Therapeutics Market has been segmented as below:
Sexually Transmitted Disease Therapeutics Market, By Type
Sexually Transmitted Disease Therapeutics Market, By Location of Testing
Sexually Transmitted Disease Therapeutics Market, By Testing Device
Sexually Transmitted Disease Therapeutics Market, By Region
The report covers:
Report scope:
The scope of the report includes a detailed study of avionics market with the reasons given for variations in the growth of the industry in certain regions.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include DiaSorin, Roche Holdings AG, Alere Inc., Abbott Laboratories, Danaher Corporation, bioMerieux, Becton Dickinson and Company, Affymetrix, Hologic Inc., Cepheid Inc., and Orasure. Company profile includes assigning such as company overview, product landscape, financial overview, and recent developments.
The top company reports are intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
Customization:
We can offer you custom research reports as per client’s special requirements
Below are our New Reports :-
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Increasing prevalence rates of STD
4.2.2. Supporting Reimbursement for STDs testing
4.3. Restraints
4.3.1. Social stigma associated with patients visiting specialized STD clinics
4.3.2. Stringent regulatory abidance requirements for the participants of std market
4.4. Opportunities
4.4.1. Implementation of National Screening Program
4.4.2. Niche opportunities for technology and POC test providers in developing nations
4.5. Challenges
4.5.1. Huge proportion of patients infected with STDs in out-of-reach geographic areas
5. Sexually Transmitted Disease Therapeutics Market, By Type
5.1. Key Points
5.2. Chlamydia testing
5.3. Syphilis testing
5.4. Gonorrhoea testing
5.5. Herpes Simplex Virus testing
5.6. Human Papilloma Virus testing
5.7. Human Immunodeficiency Virus testing
5.8. Chancroid testing
5.9. Others
6. Sexually Transmitted Disease Therapeutics Market, By Location of Testing
6.1. Key Points
6.2. Laboratory Testing
6.2.1. Commercial/Private labs
6.2.2. Public Health Labs
6.3. Point of Care (PoC) testing
7. Sexually Transmitted Disease Therapeutics Market, By Testing Device
7.1. Key Points
7.2. Laboratory Devices
7.2.1. Thermal Cyclers – PCR
7.2.2. Lateral Flow Readers – Immunochromatographic assays
7.2.3. Flow Cytometers
7.2.4. Differential Light Scattering machines
7.2.5. Absorbance microplate reader – Enzyme Linked Immunosorbent Assay (ELISA)
7.2.6. Others
7.3. Point of Care (PoC) Devices
7.3.1. Phone chips (microfluidics + ICT)
7.3.2. Portable/bench top/rapid diagnostic kits
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers & Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profile
9.1. DiaSorin
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Roche Holdings AG
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. Alere Inc.
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. Abbott Laboratories
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Danaher Corporation
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. bioMerieux
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
9.7. Becton Dickinson and Company
9.7.1. Company Overview
9.7.2. Product/Service Landscape
9.7.3. Financial Overview
9.7.4. Recent Developments
9.8. Affymetrix
9.8.1. Company Overview
9.8.2. Product/Service Landscape
9.8.3. Financial Overview
9.8.4. Recent Developments
9.9. Hologic Inc.
9.9.1. Company Overview
9.9.2. Product/Service Landscape
9.9.3. Financial Overview
9.9.4. Recent Developments
9.10. Cepheid Inc.
9.10.1. Company Overview
9.10.2. Product/Service Landscape
9.10.3. Financial Overview
9.10.4. Recent Developments
9.11. Orasure
9.11.1. Company Overview
9.11.2. Product/Service Landscape
9.11.3. Financial Overview
9.11.4. Recent Developments
The Sexually Transmitted Disease Therapeutics Market has been segmented as below:
Sexually Transmitted Disease Therapeutics Market, By Type
Sexually Transmitted Disease Therapeutics Market, By Location of Testing
Sexually Transmitted Disease Therapeutics Market, By Testing Device
Sexually Transmitted Disease Therapeutics Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
